World's Best Scientists 2026 revealed!
David J. Inwards

David J. Inwards

D-Index & Metrics

Medicine

D-Index
79
Citations
19471
World Ranking
17714
National Ranking
8844

Overview

David J. Inwards is affiliated with the Mayo Clinic in the United States, contributing extensively to medical research with a focus on oncology and hematology. Their primary field of study is medicine, with significant work spanning pathology and forensic medicine, oncology, genetics, neurology, and hematology.

The scientist's research encompasses key topics including lymphoma diagnosis and treatment, chronic lymphocytic leukemia research, viral-associated cancers and disorders, CAR-T cell therapy research, CNS lymphoma diagnosis and treatment, sarcoma diagnosis and treatment, and acute lymphoblastic leukemia research.

Among their recent scientific publications are:

  • Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant, 2021, JAMA Oncology
  • Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic Transplant, 2020, JAMA Oncology
  • Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis, 2021, American Journal of Hematology
  • ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma, 2021, Bone Marrow Transplantation
  • Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation, 2020, American Journal of Hematology

The scientist collaborates frequently with other researchers, including Stephen M. Ansell, Thomas M. Habermann, Jonas Paludo, Grzegorz S. Nowakowski, and Ivana N. Micallef.

Their articles are commonly published in journals such as Blood, Journal of Clinical Oncology, Clinical Lymphoma Myeloma & Leukemia, American Journal of Hematology, and Blood Cancer Journal.

Best Publications

  • Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell Lymphoma

    Thomas E. Witzig;Susan M. Geyer;Irene Ghobrial;David J. Inwards

  • Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

    Koen Van Besien;Fausto R. Loberiza;Ruta Bajorunaite;James O. Armitage

  • Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma.

    Stephen M. Ansell;Sara A. Hurvitz;Patricia A. Koenig;Betsy R. LaPlant

  • Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.

    Angela Dispenzieri;Morie A. Gertz;Robert A. Kyle;Martha Q. Lacy

  • Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma.

    Luis F. Porrata;Morie A. Gertz;David J. Inwards;Mark R. Litzow

  • Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study

    Grzegorz S Nowakowski;Betsy LaPlant;William R Macon;Craig B Reeder

  • Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource

    Brian K. Link;Matthew J. Maurer;Grzegorz S. Nowakowski;Stephen M. Ansell

  • Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.

    Angela Dispenzieri;Martha Q. Lacy;Jerry A. Katzmann;S. Vincent Rajkumar

  • Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study.

    Angela Dispenzieri;Robert A. Kyle;Martha Q. Lacy;Terry M. Therneau

  • A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma

    Patrick Bruce Johnston;David J. Inwards;Joseph P. Colgan;Betsy R. Laplant

  • Vitamin D Insufficiency and Prognosis in Non-Hodgkin's Lymphoma

    Matthew T. Drake;Matthew J. Maurer;Brian K. Link;Thomas M. Habermann

  • Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma

    Sonali M. Smith;Linda J. Burns;Koen W. van Besien;Jennifer LeRademacher

  • Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation

    Angelo Palmas;Ayalew Tefferi;Jeffrey L. Myers;John P. Scott

  • Testicular lymphoma is associated with a high incidence of extranodal recurrence

    Rafael Fonseca;Thomas M. Habermann;Joseph P. Colgan;Brian P. O'Neill

  • Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type.

    Paul Kurtin;Jeffrey Myers;Hakiran Adlakha;John Strickler

  • Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

    Matthew J. Maurer;Emmanuel Bachy;Hervé Ghesquières;Stephen M. Ansell

  • Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group.

    Stephen M. Ansell;David J. Inwards;Kendrith M. Rowland;Patrick J. Flynn

  • How to interpret and pursue an abnormal complete blood cell count in adults.

    Ayalew Tefferi;Curtis A. Hanson;David J. Inwards

  • Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma

    Luis F. Porrata;Kay Ristow;Joseph P. Colgan;Thomas M. Habermann

  • Acquired C1 esterase inhibitor deficiency.

    Svetomir N. Markovic;David J. Inwards;Evangelos A. Frigas;Robert P. Phyliky

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering alternative ways to launch a career in healthcare, online degree programs offer diverse and flexible options. Many students look for the easiest rn program to get into as a pathway into nursing, especially when balancing work and family commitments. Accelerated or flexible entry requirements help students start their healthcare journey sooner.

For those not interested in clinical roles, administrative careers are also in high demand. Earning a health care administration degree online allows students to build essential skills for jobs in hospital management, insurance, and more, often at their own pace.

Finding schools that match your needs can be easier than you think. Some institutions are recognized as nursing schools that don't require teas, making the admission process more accessible for busy applicants.

Additionally, plenty of accredited programs focus on in-demand fields like medical billing and coding. Many reputable schools provide financial aid for medical billing and coding online classes to help offset costs and make education more attainable.

Best Scientists Citing David J. Inwards

Trending Scientists

Recently Published Articles